PHOENIX, Jan. 04, 2017 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. ("Insys" or "the Company") INSY today announced that Santosh Vetticaden, MD, PhD, Senior Vice President and Chief Medical Officer, and Darryl Baker, Chief Financial Officer, will present at the J.P. Morgan 35th Annual Healthcare Conference as follows:
| Date: | Monday, January 9, 2017 | ||
| Time: | 4:00 p.m. Pacific Standard Time | ||
| Location: | Westin St. Francis Hotel, San Francisco |
The presentation will be webcast live at the aforementioned time as well as archived for 90 days thereafter, via the Company's website at www.insysrx.com, under the Investors Section or at http://jpmorgan.metameetings.com/confbook/healthcare17/directlink?p=22495.
About Insys Therapeutics, Inc.
Insys Therapeutics is a specialty pharmaceutical company that develops and commercializes innovative drugs and novel drug delivery systems of therapeutic molecules that improve the quality of life of patients.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
